Mangaceuticals Inc. (MGRX)
NASDAQ · Healthcare
Mangaceuticals Inc. Operating Income 2022–2025
Mangaceuticals Inc. annual/quarterly operating income history and growth rate from 2022 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Mangaceuticals Inc. operating income for the quarter ending March 31, 2026 was -3.1 M, a 31.69% decrease year-over-year.
- Mangaceuticals Inc. operating income for the twelve months ending March 31, 2026 was -20.5 M, a 153.46% increase year-over-year.
- Mangaceuticals Inc. annual operating income for 2025 was -18.0 M, a 126.20% increase from 2024.
- Mangaceuticals Inc. annual operating income for 2024 was -8.0 M, a 13.53% decrease from 2023.
- Mangaceuticals Inc. annual operating income for 2023 was -9.2 M, a 362.89% increase from 2022.
- Mangaceuticals Inc. annual operating income for 2022 was -2.0 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Mangaceuticals Inc. Operating Income — FAQ
Mangaceuticals Inc. (MGRX) operating income over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
What is Mangaceuticals Inc.'s operating income?
Mangaceuticals Inc. (MGRX) reported operating income of -$18M for fiscal 2025.
Where can I see MGRX's operating income history?
The chart and table above show Mangaceuticals Inc.'s operating income by year and by quarter, including the growth rate.